Composition of Valmet’s Nomination Board

World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA

MAKER’S MARK WHISKY PARTNERS WITH ACTOR LUCIEN LAVISCOUNT, CALLING BRITS TO MARK MOMENTS THAT MATTER WITH AN OLD-FASHIONED COCKTAIL

Europe’s Must-See Exhibition ‘House of Dreamers’ Arrives In London This Summer

Forus selects Elisa Industriq’s Gridle to operate 15 MW of battery storage in Finland